Outcome-oriented and patient-experienced impact of the COVID-19 pandemic on healthcare accessibility and use of rheumatological care in the Netherlands
- Funded by Netherlands Organisation for Health Research and Development (ZonMW)
- Total publications:0 publications
Grant number: 05160482310002
Grant search
Key facts
Disease
COVID-19Start & end year
20232025Funder
Netherlands Organisation for Health Research and Development (ZonMW)Principal Investigator
dr. D Lopes barreto PhDResearch Location
N/ALead Research Institution
Maasstad ZiekenhuisResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Other
Occupations of Interest
Unspecified
Abstract
During the COVID-19 pandemic, there was reduced accessibility to outpatient care for rheumatoid arthritis (RA) patients due to care downscaling, but also because some patients chose to avoid the overburdened healthcare system. As a result, rheumatological care has been delivered in a different way, including the accelerated adaptation of remote care. Goal The aim of this quantitative and qualitative research is to use outcome information to substantiate the knowledge gap as to whether the (drug) treatment for RA patients was optimal during the COVID-19 pandemic by reducing the number of physical consultations. Method By using real-world data, we gain insight into the further development of appropriate care during the accelerated implementation of care substitution. This knowledge will be used to optimize the care process and as a starting point for the outcome-oriented delivery of rheumatological care from a social and patient perspective.